JT010

CAS No. 917562-33-5

JT010( —— )

Catalog No. M26725 CAS No. 917562-33-5

JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 28 In Stock
5MG 46 In Stock
10MG 73 In Stock
25MG 150 In Stock
50MG 235 In Stock
100MG 351 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JT010
  • Note
    Research use only, not for human use.
  • Brief Description
    JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
  • Description
    JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    LXRα| LXRβ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    917562-33-5
  • Formula Weight
    354.85
  • Molecular Formula
    C16H19ClN2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (281.81 mM)
  • SMILES
    COCCCN(C(=O)CCl)c1nc(cs1)-c1ccc(OC)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Griffett K, et al. A liver-selective LXR inverse agonist that suppresses hepatic steatosis. ACS Chem Biol. 2013 Mar 15;8(3):559-67.
molnova catalog
related products
  • SB269970 HCl

    SB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.

  • Supercinnamaldehyde

    Supercinnamaldehyde is a transient receptor potential anchor protein 1 (TRPA1) activator with thousands of anticancer and antimicrobial activities.

  • UNC-2025

    UNC-2025( IC50 of 0.74 nM and 0.8 nM) is a potent and orally bioavailable dual MER/FLT3 inhibitor. UNC-2025 is about 20-fold selectivity higher than Axl and Tyro3.